Health tech Amid social distancing and other measures to help reduce the spread of coronavirus, digital therapeutics have come into sharper focus. (Image: Shutterstock)

Digital therapeutics are enjoying renewed attention amid the coronavirus crisis, and new industry analyses assert that health benefits managers and advisers might consider these prescription software alternatives as the cost of health care rises.

“Digital therapeutics are poised to change health care by allowing for the diagnosis, management, and treatment of medical conditions in a low-cost, scalable way,” the Boston-based tech advisory firm Lux Research said in a new analysis. “All health care stakeholders will be impacted by the adoption of this technology.”

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.